DPI Research

The global mammography devices market was valued at USD 2.35 billion in 2024, and is expected to reach USD 4.67 billion by 2033, rising at a CAGR of 7.8% during the forecast period.

The global x-ray system market was valued at USD 18.6 billion in 2024, and is expected to reach USD 32 billion by 2033, rising at a CAGR of 6.2% during the forecast period.

The global HbA1c testing market size was valued at USD 2,416 million in 2024 and is projected to hit around USD 3,858 million by 2033, growing at a CAGR of 5.5% during the forecast period 2025 to 2033.

The global AI in biotechnology market was valued at USD 3.23 billion in 2024, and is expected to reach USD 14.97 billion by 2033, rising at a CAGR of 21.1% during the forecast period.

The United States ready meals and soup market size was valued at US$ 64.9 billion in 2024 and is likely to reach USD 82.8 billion by 2032, expanding at a CAGR 3% during the forecast period.

The global gene editing market size was valued at USD 6 billion in 2024 and is likely to reach USD 22 billion by 2033, expanding at a CAGR 15.6% during the forecast period.

The global multi cancer early detection market size was valued at USD 1 billion in 2024 and is likely to reach USD 4.3 billion by 2033, expanding at a CAGR 16.9% during the forecast period.

The global gene editing market size was valued at USD 6 billion in 2024 and is likely to reach USD 22 billion by 2033, expanding at a CAGR 15.6% during the forecast period.

The global clinical next generation sequencing (NGS) market size was valued at USD 6.2 billion in 2024 and is projected to surpass around USD 15.2 billion by 2032, registering a CAGR of 13.6% over the forecast period of 2025 to 2032

The global clinical next generation sequencing (NGS) market size was valued at USD 6.2 billion in 2024 and is projected to surpass around USD 15.2 billion by 2032, registering a CAGR of 13.6% over the forecast period of 2025 to 2032